Locations - Glenmark Pharmaceuticals Ltd.
Search Company
Registered Address
Registered Office : B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road,
Mumbai, Maharashtra - 400026
Tel: 022-40189999, 40189879
Fax: 022-40189986
Email : complianceofficer@glenmarkpharma.com
Website : http://www.glenmarkpharma.com
Key Officials
Name Designation
Mr. Harish Kuber Co. Secretary & Compl. Officer
Listings
BSE , MCXSX , NSE ,  
Standalone Consolidated
You are viewing standalone data.
Quarterly Results
Mar 25 Dec 24 Sep 24
Sales 2,009.49 2,251.28 2,636.10
Other Income 88.45 129.19 83.08
Total Expenses 1,577.48 1,668.27 1,753.83
Operating Profit 432.01 583.02 882.28
Interest 13.13 8.46 11.80
Gross Profit 415.85 614.65 849.91
Provisions Made 0.00 0.00 0.00
Depreciation 55.53 55.16 54.85
Taxation 33.40 145.69 200.00
Net Profit / Loss 147.76 413.80 595.06
Equity Capital 28.22 28.22 28.22
Balance Sheet
Mar 25 Mar 24 Mar 23
Share Capital 28.22 28.22 28.22
Reserve & Surplus 24,475.74 22,939.89 17,849.25
Revaluation Reserve 0.00 0.00 0.00
Networth 24,503.96 22,970.63 17,877.47
Total debt 698.82 657.24 3,156.40
Total Liability 25,202.78 23,627.87 21,033.87
Net Block 2,133.74 1,756.25 1,745.94
Capital work in progress 0.00 197.67 172.34
Investment 15,194.91 12,964.79 10,334.01
Net current asset 7,874.13 8,709.15 8,781.57
Miscellaneous expenses 0.00 0.00 0.00
Total Assets 25,202.78 23,627.85 21,033.86
Income Statement
  Mar25 Mar24 Mar23
Sales 9,226.41 7,891.12 8,220.66
Other Income 356.37 1,168.02 985.94
Total Expenses 6,982.23 6,649.46 6,747.91
Operating Profit 2,244.18 1,241.66 1,472.77
Interest 48.73 277.11 206.82
Adjusted PBDIT 2,600.55 2,409.69 2,458.71
Depreciation 218.63 202.16 184.15
Adjusted PBT 2,333.18 1,930.42 2,067.74
Taxation 543.67 1,833.46 363.11
Net Profit / Loss 1,610.35 5,167.29 1,208.77
Key Ratios
  Mar25 Mar24 Mar23
OPM (%) 24.32 15.73 17.91
GPM (%) 21.95 13.17 15.67
NPM (%) 17.45 65.48 14.70
Earning Retention Ratio 100.00 27.25 95.87
Return on networth (%) 6.57 22.49 6.76
EPS (Rs.) 57.07 183.13 42.84
Dividend payout Ratio 0.00 1.36 5.83
Longterm Debt-Equity Ratio 0.00 0.00 0.14
Current Ratio 3.78 3.30 3.47
Fixed Asset Turnover Ratio 0.37 0.35 0.39
Inventory 0.36 0.33 0.39
Interest coverage Ratio 53.36 8.70 11.89
Registrar Details
KFIN Technologies Pvt. Ltd.
Selenium Tower B, Plot No. 31-32,Gachibowli, Financial District, Nanakramguda,Serilingampally Man
Hyderabad,500032,Telangana
Tel : 040-67161500
Fax : 23420814
Market Performance
Exchange BSE NSE
Last Traded Price (Rs.) 2,181.55 2,181.10
Last Traded Date 11/07/2025 11/07/2025
Last Traded Time - -
Change (%) 14.51% 14.55%
Day's Open (Rs.) 2,095.65 2,094.40
Previous Close (Rs.) 1,905.15 1,904.00
Day's High (Rs.) 2,286.15 2,284.80
Day's Low (Rs.) 2,095.65 2,094.40
Volume (Rs. In Lacs) 17963.41 342710.39
Bid Price (Rs.) 0.00 0.00
Bid Quantity
Offer Price (Rs.) 0.00 0.00
Offer Quantity
Exchange Code 532296 GLENMARKEQ
Exchange Group A OtherEQ
Board Meetings
Date Purpose
23/05/2025 Audited Results & Final Dividend
14/02/2025 Quarterly Results
14/11/2024 Quarterly Results
Corporate News
Glenmark Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Glenmark Pharma - Analysts/Institutional Investor Meet/Con. Call Updates
Glenmark Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Glenmark Pharma - Press Release
Glenmark Pharma - Press Release
Share Holding Pattern as on 31/03/2025
Major Holder No. of Shares Percentage (%)
Promoters 131,632,937 46.65
Institutional Investors 106,552,027 37.76
Other Investors 9,248,816 3.28
General Public 34,754,376 12.32